|
1
|
Ramsdale E, van Besien K and Smith SM:
Personalized treatment of lymphoma: promise and reality. Semin
Oncol. 38:225–235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hadzi-Pecova L, Petrusevska G and
Stojanovic A: Non-Hodgkin's lymphomas: immunologic prognostic
studies. Prilozi. 28:39–55. 2007.
|
|
3
|
Alizadeh AA, Ross DT, Perou CM and van de
Rijn M: Towards a novel classification of human malignancies based
on gene expression patterns. J Pathol. 195:41–52. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Y, de Reyniès A, de Leval L, Ghazi
B, Martin-Garcia N, Travert M, Bosq J, Brière J, Petit B, Thomas E,
et al: Gene expression profiling identifies emerging oncogenic
pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Blood. 115:1226–1237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kleppe M, Tousseyn T, Geissinger E,
Kalender Atak Z, Aerts S, Rosenwald A, Wlodarska I and Cools J:
Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's
lymphoma and T-cell non-Hodgkin's lymphoma. Haematologica.
96:1723–1727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fernberg P, Chang ET, Duvefelt K, Hjalgrim
H, Eloranta S, Sørensen KM, Porwit A, Humphreys K, Melbye M and
Ekström Smedby K: Genetic variation in chromosomal translocation
breakpoint and immune function genes and risk of non-Hodgkin
lymphoma. Cancer Causes Control. 21:759–769. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramos JC and Lossos IS: Newly emerging
therapies targeting viral-related lymphomas. Curr Oncol Rep.
13:416–426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Emdad L, Sarkar D, Su ZZ, Randolph A,
Boukerche H, Valerie K and Fisher PB: Activation of the nuclear
factor kappaB pathway by astrocyte elevated gene-1: implications
for tumor progression and metastasis. Cancer Res. 66:1509–1516.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anttila V, Stefansson H, Kallela M, et al:
Genome-wide association study of migraine implicates a common
susceptibility variant on 8q22.1. Nat Genet. 42:869–873. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky
DJ and Fisher PB: Cloning and characterization of HIV-1-inducible
astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee SG, Su ZZ, Emdad L, Sarkar D and
Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of
oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc.
Proc Natl Acad Sci USA. 103:17390–17395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC,
Bruce JN, Volsky DJ and Fisher PB: Astrocyte elevated gene-1:
recent insights into a novel gene involved in tumor progression,
metastasis and neurodegeneration. Pharmacol Ther. 114:155–170.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoo BK, Emdad L, Lee SG, Su ZZ,
Santhekadur P, Chen D, Gredler R, Fisher PB and Sarkar D: Astrocyte
elevated gene-1 (AEG-1): A multifunctional regulator of normal and
abnormal physiology. Pharmacol Ther. 130:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu C, Chen K, Zheng H, Guo X, Jia W, Li M,
Zeng M, Li J and Song L: Overexpression of astrocyte elevated
gene-1 (AEG-1) is associated with esophageal squamous cell
carcinoma (ESCC) progression and pathogenesis. Carcinogenesis.
30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan B, Wang YX, Yao T and Zhu YC: p38
mitogen-activated protein kinase mediates hypoxia-induced vascular
endothelial growth factor release in human endothelial cells. Acta
Physiol Sin. 57:13–20. 2005.
|
|
17
|
Shen YM, Yang XC, Song ML, Qin CH, Yang C
and Sun YH: Growth inhibition induced by short hairpin RNA to
silence survivin gene in human pancreatic cancer cells.
Hepatobiliary Pancreat Dis Int. 9:69–77. 2010.PubMed/NCBI
|
|
18
|
Vose JM: Peripheral T-cell non-Hodgkin's
lymphoma. Hematol Oncol Clin North Am. 22:997–1005. 2008.
View Article : Google Scholar
|
|
19
|
Fornari A, Piva R, Chiarle R, Novero D and
Inghirami G: Anaplastic large cell lymphoma: one or more entities
among T-cell lymphoma? Hematol Oncol. 27:161–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Windsor R, Stiller C and Webb D:
Peripheral T-cell lymphoma in childhood: population-based
experience in the United Kingdom over 20 years. Pediatr Blood
Cancer. 50:784–787. 2008.PubMed/NCBI
|
|
21
|
Kossakowska AE, Edwards DR, Prusinkiewicz
C, Zhang MC, Guo D, Urbanski SJ, Grogan T, Marquez LA and
Janowska-Wieczorek A: Interleukin-6 regulation of matrix
metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of
metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's
lymphomas. Blood. 94:2080–2089. 1999.PubMed/NCBI
|
|
22
|
Chow KU, Boehrer S, Geduldig K, Krapohl A,
Hoelzer D, Mitrou PS and Weidmann E: In vitro induction of
apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas
using combinations of established cytotoxic drugs with
bendamustine. Haematologica. 86:485–493. 2001.
|
|
23
|
Sebti Y, Le Maux A, Gros F, De Guibert S,
Pangault C, Rouas-Freiss N, Bernard M and Amiot L: Expression of
functional soluble human leucocyte antigen-G molecules in
lymphoproliferative disorders. Br J Haematol. 138:202–212. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J, Wang S, Zhao G and Sun B: Effect
of chemokine receptors CCR7 on disseminated behavior of human T
cell lymphoma: clinical and experimental study. J Exp Clin Cancer
Res. 30:51–59. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sarkar D, Emdad L, Lee SG, Yoo BK, Su ZZ
and Fisher PB: Astrocyte elevated gene-1: far more than just a gene
regulated in astrocytes. Cancer Res. 69:8529–8535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Ke Z, Shi H, Yang S and Wang L:
Overexpression of AEG-1 in renal cell carcinoma and its correlation
with tumor nuclear grade and progression. Neoplasma. 57:522–529.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song H, Li C, Li R and Geng J: Prognostic
significance of AEG-1 expression in colorectal carcinoma. Int J
Colorectal Dis. 25:1201–1209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li C, Li R, Song H, Wang D, Feng T, Yu X,
Zhao Y, Liu J, Yu X, Wang Y and Geng J: Significance of AEG-1
expression in correlation with VEGF, microvessel density and
clinicopathological characteristics in triple-negative breast
cancer. J Surg Oncol. 103:184–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun W, Fan YZ, Xi H, Lu XS, Ye C and Zhang
JT: Astrocyte elevated gene-1 overexpression in human primary
gallbladder carcinomas: An unfavorable and independent prognostic
factor. Oncol Rep. 26:1133–1142. 2011.PubMed/NCBI
|
|
30
|
Li C, Liu J, Lu R, Yu G, Wang X, Zhao Y,
Song H, Lin P, Sun X, Yu X, Zhang Y, Ning X and Geng J: AEG-1
overexpression: a novel indicator for peritoneal dissemination and
lymph node metastasis in epithelial ovarian cancers. Int J Gynecol
Cancer. 21:602–608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song H, Li C, Lu R, Zhang Y and Geng J:
Expression of astrocyte elevated gene-1: a novel marker of the
pathogenesis, progression, and poor prognosis for endometrial
cancer. Int J Gynecol Cancer. 20:1188–1196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoo BK, Chen D, Su ZZ, Gredler R, Yoo J,
Shah K, Fisher PB and Sarkar D: Molecular mechanism of
chemoresistance by astrocyte elevated gene-1. Cancer Res.
70:3249–3258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu JB, Wu H, He YL, Zhang CH, Zhang LJ,
Cai SR and Zhan WH: Astrocyte-elevated gene-1 overexpression is
associated with poor prognosis in gastric cancer. Med Oncol.
28:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song L, Li W, Zhang H, Liao W, Dai T, Yu
C, Ding X, Zhang L and Li J: Over-expression of AEG-1 significantly
associates with tumour aggressiveness and poor prognosis in human
non-small cell lung cancer. J Pathol. 219:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khuda II, Koide N, Noman AS, Dagvadorj J,
Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T and Yokochi T: Astrocyte
elevated gene-1 (AEG-1) is induced by lipopolysaccharide as
toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling.
Immunology. 128:700–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche
H, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1)
functions as an oncogene and regulates angiogenesis. Proc Natl Acad
Sci USA. 106:21300–21305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kehinde EO, Maghrebi MA and Anim JT: The
importance of determining the aggressiveness of prostate cancer
using serum and tissue molecular markers. Can J Urol. 15:3967–3974.
2008.PubMed/NCBI
|
|
38
|
Nardiello T, Jungbluth AA, Mei A, et al:
MAGE-A inhibits apoptosis in proliferating myeloma cells through
repression of Bax and maintenance of survivin. Clin Cancer Res.
17:4309–4319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jamieson NB, Carter CR, McKay CJ and Oien
KA: Tissue biomarkers for prognosis in pancreatic ductal
adenocarcinoma: a systematic review and meta-analysis. Clin Cancer
Res. 17:3316–3331. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu L, Wu J, Ying Z, Chen B, Han A, Liang
Y, Song L, Yuan J, Li J and Li M: Astrocyte elevated gene-1
upregulates matrix metalloproteinase-9 and induces human glioma
invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang F, Ke ZF, Sun SJ, Chen WF, Yang SC,
Li SH, Mao XP and Wang LT: Oncogenic roles of astrocyte elevated
gene-1 (AEG-1) in osteosarcoma progression and prognosis. Cancer
Biol Ther. 12:539–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nelson AR, Fingleton B, Rothenberg ML and
Matrisian LM: Matrix metalloproteinases: biologic activity and
clinical implications. J Clin Oncol. 18:1135–1149. 2000.PubMed/NCBI
|
|
43
|
Peschos D, Damala C, Stefanou D, Tsanou E,
Assimakopoulos D, Vougiouklakis T, Charalabopoulos K and Agnantis
NJ: Expression of matrix metalloproteinase-9 (gelatinase B) in
benign, premalignant and malignant laryngeal lesions. Histol
Histopathol. 21:603–608. 2006.PubMed/NCBI
|
